Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 :
Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 : report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office).
- 1 online resource (59 pages).
- Report / 116th Congress, 1st session, House of Representatives ; 116-46 .
- United States. Congress. House. Report ; 116-46. .
"May 2, 2019." CRDP Program record.
Includes bibliographical references.
Pharmaceutical industry--Quality control.--United States
Generic drugs--Standards--United States.
Generic drugs--Effectiveness--United States.
Generic drugs--Prices.
Drugs--Cost effectiveness.--United States
Legislative materials.
KF32 / .E55 2019g
1008-I (online)
Y 1.1/8:116-46
"May 2, 2019." CRDP Program record.
Includes bibliographical references.
Pharmaceutical industry--Quality control.--United States
Generic drugs--Standards--United States.
Generic drugs--Effectiveness--United States.
Generic drugs--Prices.
Drugs--Cost effectiveness.--United States
Legislative materials.
KF32 / .E55 2019g
1008-I (online)
Y 1.1/8:116-46